Abstract
BackgroundBecause of the extremely variable incidence and outcome of interstitial lung disease (ILD) in polymyositis/dermatomyositis (PM/DM), exploration and validation of biomarkers for diagnosis, prognosis, and response to treatment is mandatory....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have